ASRAPM: Adjust Use of Contrast for Pain Procedures During Shortage

FRIDAY, June 3, 2022 (HealthDay News) — Recommendations have been issued by the American Society of Regional Anesthesia (ASRA) and Pain Medicine for interventional pain procedures during the current contrast shortage.

Lynn Kohan, M.D., from ASRA, and colleagues developed recommendations for interventional pain procedures during the current contrast shortage, resulting from the shutdown of a production facility in Shanghai.

The authors note that risk stratification should be used to determine which procedures can be delayed until contrast supply resumes. Alternative forms of visualization, such as ultrasound, should be considered when feasible. The use of gadolinium can be considered in non-neuraxial injections. Gadolinium-based contrast agents should not be used in spine-related procedures in the absence or shortage of iodinated contrast medium. Lumbar interlaminar epidural injections, sacroiliac and facet joint injections, lumbar medial branch blocks, and radiofrequency denervation can be performed without use of contrast.

Whenever possible, multidose vials should be used for single patients. If a multidose vial is to be used for more than one patient, the U.S. Pharmacopeia 797 standard of practice as well as U.S. Centers for Disease Control and Prevention guidelines must be followed. Following the guidance of the state board of pharmacy or other regulatory body also is recommended.

More Information